FDA Inspection 1210949 — Sun Pharmaceutical Medicare Limited

Sun Pharmaceutical Medicare Limited — FEI 3002957541

The FDA completed an inspection of Sun Pharmaceutical Medicare Limited on July 13, 2023 in Halol. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Halol (India)

Citations

IDCFRDescription
440221 CFR 211.192Written record of investigation incomplete